NEW YORK (GenomeWeb) – Nanosphere today announced after the close of the market that its first quarter revenues rose 41 percent on sales of its Verigene Gram Positive and Gram Negative Blood Culture Tests.

The firm also said that it has entered into a definitive agreement with an institutional investor in a registered direct offering of $4.4 million and entered into a new $30 million debt facility with NSPH Funding.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.